Cholecystokinin Receptor Antagonist Suppresses Melanoma Growth by Inducing Apoptosis of Tumor Cells

Melanoma is a malignant skin tumor with high metastatic activity. Although melanoma has been well-studied, its cellular kinetics remain elusive. The cholecystokinin (CCK) receptor is expressed in various types of tumors because CCK promotes the survival and proliferation of tumor cells. Thus, we hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Funakoshi, Atsuko, Honda, Tetsuya, Ito, Taisuke, Tokura, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573926/
https://www.ncbi.nlm.nih.gov/pubmed/36262666
http://dx.doi.org/10.1016/j.xjidi.2022.100153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573926/
https://www.ncbi.nlm.nih.gov/pubmed/36262666
http://dx.doi.org/10.1016/j.xjidi.2022.100153

Ejemplares similares